Ivory Investment Management’s Elevance Health ELV Stock Holding History

Ivory Investment Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-185,020	Closed	-$40.6M	–	33
2018 Q1	$40.6M	Buy	185,020 +26,775	+17%	+$6.29M	2.46%	15
2017 Q4	$35.6M	Sell	158,245 -46,309	-23%	-$9.86M	2.04%	19
2017 Q3	$38.8M	Sell	204,554 -186,414	-48%	-$35.5M	1.93%	22
2017 Q2	$73.6M	Buy	390,968 +22,052	+6%	+$3.96M	2.74%	11
2017 Q1	$61M	Buy	+368,916	New	+$58.7M	2.16%	15
2016 Q2	–	Sell	-102,889	Closed	-$14.3M	–	100
2016 Q1	$14.3M	Buy	102,889 +59,503	+137%	+$7.95M	0.5%	52
2015 Q4	$6.05M	Buy	+43,386	New	+$5.98M	0.16%	72
2014 Q1	–	Sell	-11,886	Closed	-$1.1M	–	206
2013 Q4	$1.1M	Sell	11,886 -9,605	-45%	-$853K	0.05%	160
2013 Q3	$1.8M	Sell	21,491 -486,349	-96%	-$41.7M	0.09%	100
2013 Q2	$41.6M	Buy	+507,840	New	+$38M	1.71%	15

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Ivory Investment Management's ELV Position: Q2 2018 in Review

Ivory Investment Management sold out of Elevance Health (ELV) in Q2 2018, closing a stake of 185,020 shares — an estimated $40.6M sold.

Ivory Investment Management first reported a position in ELV in Q2 2013 and held it in 10 quarters. The position peaked at $73.6M in Q2 2017. 935 funds tracked by Wall St. Rank hold ELV as of Q2 2018.

Ivory Investment Management reported no remaining Elevance Health position as of Q2 2018 after selling out during the quarter.
Ivory Investment Management sold 185,020 Elevance Health shares in Q2 2018, an estimated $40.6M.
Ivory Investment Management first reported a position in Elevance Health in Q2 2013 and held it in 10 quarters.
Ivory Investment Management's Elevance Health position peaked at $73.6M in Q2 2017.
935 funds tracked by Wall St. Rank held Elevance Health as of Q2 2018.

Based on Ivory Investment Management's 13F filing for Q2 2018, filed 14 Aug 2018.